AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 1
Completed
- Conditions
- Refractory Ovarian CarcinomaPlatinum-Resistant Ovarian CarcinomaRecurrent Fallopian Tube CarcinomaRefractory Fallopian Tube CarcinomaPlatinum-Resistant Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal CarcinomaPlatinum-Resistant Primary Peritoneal CarcinomaRefractory Primary Peritoneal Carcinoma
- Interventions
- First Posted Date
- 2019-07-15
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT04019288
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer
Phase 1
Active, not recruiting
- Conditions
- BRAF NP_004324.2:p.V600EMetastatic Colon AdenocarcinomaMetastatic Microsatellite Stable Colorectal CarcinomaMetastatic Rectal AdenocarcinomaProgressive DiseaseRecurrent Colorectal CarcinomaStage III Colorectal Cancer AJCC v8Stage IIIA Colorectal Cancer AJCC v8Stage IIIB Colorectal Cancer AJCC v8Stage IIIC Colorectal Cancer AJCC v8
- Interventions
- First Posted Date
- 2019-07-12
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 38
- Registration Number
- NCT04017650
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer
Phase 1
Active, not recruiting
- Conditions
- Stage IIB Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8EGFR Gene MutationLocally Advanced Lung Non-Small Cell CarcinomaLung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8ALK Gene Rearrangement
- Interventions
- First Posted Date
- 2019-07-09
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 21
- Registration Number
- NCT04013542
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Quit4Health Intervention in Supporting Smoking Cessation and Preventing Smoking Initiation in Young Adults
Not Applicable
Completed
- Conditions
- Current SmokerCigarette Smoking
- Interventions
- Other: Educational InterventionBehavioral: Smoking Cessation InterventionOther: Questionnaire Administration
- First Posted Date
- 2019-07-05
- Last Posted Date
- 2021-01-22
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 579
- Registration Number
- NCT04009590
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Web-Based Program in Helping Patients with Head and Neck Cancer Adhere to Swallowing Exercises and Coping Strategies
Phase 2
Recruiting
- Conditions
- Throat Carcinoma
- Interventions
- Other: Internet-Based InterventionOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2019-07-01
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 300
- Registration Number
- NCT04003051
- Locations
- 🇺🇸
Texas Health Care-Otolaryngology and Plastic Surgery Associates, Fort Worth, Texas, United States
🇺🇸M D Anderson Cancer Center, Houston, Texas, United States
Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery
Not Applicable
Recruiting
- Conditions
- Malignant Breast NeoplasmMammoplasty PatientBody Mass Index Greater Than or Equal to 30Obesity
- Interventions
- Procedure: Wound Care ManagementProcedure: Negative Pressure Wound Therapy
- First Posted Date
- 2019-07-01
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 80
- Registration Number
- NCT04003038
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
An Investigational Surgical Procedure (Vascularized Lymph Node Transfer) in Reducing the Risk of Lymphedema in Patients With Breast Cancer Undergoing Breast Reconstruction
Not Applicable
Active, not recruiting
- Conditions
- Breast Carcinoma
- Interventions
- Procedure: MammoplastyProcedure: Vascularized Lymph Node Transfer
- First Posted Date
- 2019-06-19
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT03990610
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Phase 2
Completed
- Conditions
- Recurrent Adenoid Cystic CarcinomaMetastatic Adenoid Cystic CarcinomaProgressive Disease
- Interventions
- First Posted Date
- 2019-06-19
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT03990571
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord
Phase 1
Withdrawn
- Conditions
- Malignant Intracranial Germ Cell TumorEpendymomaCentral Nervous System SarcomaGliomaPrimary Central Nervous System NeoplasmMedulloblastomaPineoblastoma
- Interventions
- Other: Placebo AdministrationOther: Questionnaire AdministrationDrug: Wound Dressing Material
- First Posted Date
- 2019-06-19
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT03990597
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
CT Perfusion Scans in Detecting Changes in Blood Flow to the Liver After Portal Vein Embolization
Not Applicable
Recruiting
- Conditions
- Liver and Intrahepatic Bile Duct Carcinoma
- Interventions
- Radiation: Computed Tomography Perfusion ImagingProcedure: Liver Biopsy
- First Posted Date
- 2019-06-19
- Last Posted Date
- 2023-04-07
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 22
- Registration Number
- NCT03990623
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath